Detox Made Up 17 Percent of Treatment Admissions in 2024

Alcohol was the leading reason people entered substance use treatment in 2024, and roughly one medical detox treatment admission in six was for withdrawal management rather than ongoing treatment. Those figures come from SAMHSA’s Treatment Episode Data Set released July 30, and they reveal something important about where medical detox actually sits in the system.

The report counted 1,583,823 admissions to treatment services reported by state agencies in 2024, along with 1,284,867 discharges.

Where Detox Fits Among Admissions

SAMHSA breaks admissions out by service type. Four of those categories are withdrawal management:

• Free-standing residential detox: 198,680 admissions, or 12.5 percent
• Hospital inpatient detox: 29,256 admissions, or 1.8 percent
• Medication-assisted opioid therapy detox: 32,488 admissions, or 2.1 percent
• Ambulatory detox: 10,783 admissions, or 0.7 percent

Together, those totaled about 17 percent of all admissions. Non-intensive outpatient care was the single largest category at 40.7 percent.

The split between the two residential detox settings is worth noting. Free-standing residential detox, which SAMHSA describes as comparable to clinically managed residential withdrawal management, accounted for nearly seven times as many admissions as hospital inpatient detox, the setting reserved for people with severe medical complications during withdrawal.

Alcohol Led, and Opioid Patterns Shifted

Alcohol was the primary substance in 36.5 percent of admissions, or 481,398 episodes, up from 34.1 percent in 2020. Methamphetamine followed at 14.2%.

The opioid picture changed shape over five years rather than shrinking. Heroin fell from 22.8 percent of admissions in 2020 to 11.0 percent in 2024, while other opiates and synthetics, a category that includes fentanyl along with prescription opioids, rose from 7.7 percent to 13.8 percent. Benzodiazepines were the primary substance in 0.8 percent of admissions.

For withdrawal management, that mix matters. Alcohol and benzodiazepines are the two substances where unsupervised withdrawal can kill, and between them they account for more than a third of admissions.

Why Medical Detox Matters

Alcohol withdrawal can produce seizures and can progress to delirium tremens, a state of severe confusion and autonomic instability with a genuine mortality risk. Benzodiazepine withdrawal carries a comparable seizure risk and often requires a slow, structured taper rather than an abrupt stop.

Neither should be attempted without medical supervision. Medical detox means clinical staff monitoring vital signs and withdrawal severity, treating symptoms with medication where indicated, and escalating care if complications develop.

Opioid withdrawal is rarely fatal on its own. Its danger sits after the fact, because tolerance drops during abstinence and returning to a previous dose raises overdose risk sharply.

Understanding Medication-Assisted Treatment

The TEDS data show why detox by itself is an incomplete plan for opioid use disorder. Clients in medication-assisted opioid therapy outpatient services had the longest average stay of any service type at 312 days, with a median of 86 days. Detox services had the shortest stays of any category.

Methadone, dispensed through licensed opioid treatment programs, and buprenorphine, available from certified prescribers, both reduce withdrawal symptoms and cravings. Naltrexone blocks opioid effects but requires full detoxification first. Starting one of these during or immediately after withdrawal management is what turns a short stay into continuing care.

What Happens After Detox

Among 2024 detox discharges, 47.8 percent completed treatment, 24.9 percent dropped out, and 17 percent transferred to further treatment. That transfer figure is the step-down pathway working as intended.

Two other discharge measures are worth reading together. The share of clients reporting no attendance at a substance use self-help group in the prior 30 days fell from 75.5 percent at admission to 61.6 percent at discharge. The share reporting abstinence rose from 31.2 percent to 42.3 percent.

Finding Medical Detox Centers

Questions worth asking any program include how withdrawal severity is assessed, whether the facility can manage medical complications on site, whether medication for opioid use disorder is started during detox rather than only recommended afterward, and what the step-down plan looks like.

Never attempt alcohol or benzodiazepine detox without medical supervision. If withdrawal has already started and symptoms include confusion, a racing heart, tremors or a seizure, that is an emergency, not a scheduling question.

Search for medically supervised detox programs near you to compare levels of care, insurance accepted, and whether medication-assisted treatment is available on site.